Reintegration grant: Identification of potential drugs abolishing the effect of specific mutations in soluble guanyl cyclase for risk management in myocardial infarction

Institution Universität zu Lübeck
Project leader Stephanie Tennstedt
Site Hamburg/Kiel/Lübeck
Project type Exzellenzprogramm
Funding € 27.499,98
Begin 01.07.2016
End 31.12.2016

Förderkennzeichen
81X3700103

Projektnummer
796